González-Martínez, I., Cerro-Herreros, E., Carrascosa-Sàez, M., García-Rey, A., Piqueras-Losilla, D., Colom-Rodrigo, A., . . . Artero, R. (2026). Enhanced muscle uptake of chemically optimized miR-23b antisense oligonucleotides as lead compounds for myotonic dystrophy type 1.
Citación estilo ChicagoGonzález-Martínez, Irene, et al. Enhanced Muscle Uptake of Chemically Optimized MiR-23b Antisense Oligonucleotides As Lead Compounds for Myotonic Dystrophy Type 1. 2026.
Cita MLAGonzález-Martínez, Irene, et al. Enhanced Muscle Uptake of Chemically Optimized MiR-23b Antisense Oligonucleotides As Lead Compounds for Myotonic Dystrophy Type 1. 2026.
Precaución: Estas citas no son 100% exactas.